Figure 2. AURKB could independently predict the survival of lung adenocarcinoma. (A) AURKB expression distribution in all tumor samples; (B) High AURKB expression led to worse overall survival in the TCGA-LUAD cohort (HR[95%CI]: 1.593[1.18-2.14], p = 0.002). (C) High AURKB expression correlated with poor progression-free survival in the TCGA-LUAD cohort (HR[95%CI]: 1.415[1.07-1.86], p = 0.013). (D) Multivariate analysis showed AURKB and N stage were independent prognosis factor in the TCGA-LUAD cohort (HR[95%CI]: 1.672[1.045-2.674], 1.897[1.13-3.184], respectively). (E) Meta-analysis of AURKB expression in the prediction of overall survival of lung adenocarcinoma patients from different datasets by Lung Cancer Explorer (LCE).